Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Identifieur interne : 000D57 ( Main/Exploration ); précédent : 000D56; suivant : 000D58Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
Auteurs : J A Gegúndez-Fernández [Espagne] ; J. Zarranz-Ventura [Espagne] ; G. Garay-Aramburu [Espagne] ; F J Mu Oz-Negrete [Espagne] ; J. Mendicute Del Barrio [Espagne] ; L. Pablo-Júlvez [Espagne] ; S. García-Delpech [Espagne] ; A. L Pez-Alemany [Espagne] ; F. Arnalich-Montiel [Espagne] ; M. Cordero-Coma [Espagne] ; J A Cárceles [Espagne]Source :
- Archivos de la Sociedad Espanola de Oftalmologia [ 2173-5794 ] ; 2020.
Descripteurs français
- KwdFr :
- Abstention thérapeutique (MeSH), Antipaludiques (usage thérapeutique), Betacoronavirus (MeSH), Chloroquine (usage thérapeutique), Complications postopératoires (prévention et contrôle), Espagne (MeSH), Facteurs de risque (MeSH), Humains (MeSH), Hydroxychloroquine (usage thérapeutique), Infections à coronavirus (diagnostic), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Lentilles de contact (MeSH), Maladies asymptomatiques (MeSH), Maladies de l'oeil (diagnostic), Maladies de l'oeil (thérapie), Ophtalmologie (MeSH), Pandémies (prévention et contrôle), Pneumopathie virale (diagnostic), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (transmission), Pneumopathie virale (épidémiologie), Procédures de chirurgie ophtalmologique (effets indésirables), Procédures de chirurgie ophtalmologique (méthodes), Sociétés médicales (MeSH), Sécurité transfusionnelle (MeSH), Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle), Évaluation des symptômes (méthodes), Évolution de la maladie (MeSH).
- MESH :
- diagnostic : Infections à coronavirus, Maladies de l'oeil, Pneumopathie virale.
- effets indésirables : Procédures de chirurgie ophtalmologique.
- méthodes : Procédures de chirurgie ophtalmologique, Évaluation des symptômes.
- prévention et contrôle : Complications postopératoires, Infections à coronavirus, Pandémies, Pneumopathie virale, Transmission de maladie infectieuse du patient au professionnel de santé.
- thérapie : Maladies de l'oeil.
- usage thérapeutique : Antipaludiques, Chloroquine, Hydroxychloroquine, Infections à coronavirus, Pneumopathie virale.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Abstention thérapeutique, Betacoronavirus, Espagne, Facteurs de risque, Humains, Lentilles de contact, Maladies asymptomatiques, Ophtalmologie, Sociétés médicales, Sécurité transfusionnelle, Évolution de la maladie.
- Wicri :
- geographic : Espagne.
English descriptors
- KwdEn :
- Antimalarials (therapeutic use), Asymptomatic Diseases (MeSH), Betacoronavirus (MeSH), Blood Safety (MeSH), COVID-19 (MeSH), Chloroquine (therapeutic use), Contact Lenses (MeSH), Coronavirus Infections (diagnosis), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Disease Progression (MeSH), Eye Diseases (diagnosis), Eye Diseases (therapy), Humans (MeSH), Hydroxychloroquine (therapeutic use), Infectious Disease Transmission, Patient-to-Professional (prevention & control), Ophthalmologic Surgical Procedures (adverse effects), Ophthalmologic Surgical Procedures (methods), Ophthalmology (MeSH), Pandemics (prevention & control), Pneumonia, Viral (diagnosis), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (transmission), Postoperative Complications (prevention & control), Risk Factors (MeSH), SARS-CoV-2 (MeSH), Societies, Medical (MeSH), Spain (MeSH), Symptom Assessment (methods), Withholding Treatment (MeSH).
- MESH :
- chemical , therapeutic use : Antimalarials, Chloroquine, Hydroxychloroquine.
- geographic : Spain.
- adverse effects : Ophthalmologic Surgical Procedures.
- diagnosis : Coronavirus Infections, Eye Diseases, Pneumonia, Viral.
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- methods : Ophthalmologic Surgical Procedures, Symptom Assessment.
- prevention & control : Coronavirus Infections, Infectious Disease Transmission, Patient-to-Professional, Pandemics, Pneumonia, Viral, Postoperative Complications.
- therapy : Eye Diseases.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- Asymptomatic Diseases, Betacoronavirus, Blood Safety, COVID-19, Contact Lenses, Disease Progression, Humans, Ophthalmology, Risk Factors, SARS-CoV-2, Societies, Medical, Withholding Treatment.
Abstract
OBJECTIVE
Minimize exposure to the SARS-CoV-2, reduce the chances of cross-transmission between patients and healthcare personnel, and prevent the development of postoperative complications from the management of patients with eye diseases during the 2019 coronavirus disease pandemic (COVID-19).
METHODS
COVID-19 literature review and consensus establishment between different Spanish ophthalmology societies in order to provide guidelines and recommendations of maximum resources primarily conditioned by the state of alert, confinement and social distancing that occurs in Spain since March 16, 2020.
RESULTS
The recommendations will promote the adoption of action and protection measures for eye care in outpatient clinics, surgical areas and hospitalization, for unconfirmed (asymptomatic and symptomatic) and confirmed COVID-19 patients. Measures must be adapted to the circumstances and availability of personal protective equipment in each of the centers and Autonomous Communities, which will be updated according to the pandemic phases and the measures adopted by the Spanish Government.
CONCLUSIONS
During the COVID-19 pandemic, attention to the potential health risks to the population caused by coronavirus should prevail over the possible progression of the common eye diseases. Ophthalmologists and other eye care professionals must assume a possible progression of these diseases due to the impossibility of adequate patient follow-up.
DOI: 10.1016/j.oftal.2020.04.002
PubMed: 32409243
PubMed Central: PMC7183292
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.</title><author><name sortKey="Gegundez Fernandez, J A" sort="Gegundez Fernandez, J A" uniqKey="Gegundez Fernandez J" first="J A" last="Gegúndez-Fernández">J A Gegúndez-Fernández</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid, España. Electronic address: doctorgegundez@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Zarranz Ventura, J" sort="Zarranz Ventura, J" uniqKey="Zarranz Ventura J" first="J" last="Zarranz-Ventura">J. Zarranz-Ventura</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona</wicri:regionArea><wicri:noRegion>Sociedad Española de Retina y Vítreo (SERV) Barcelona</wicri:noRegion></affiliation></author><author><name sortKey="Garay Aramburu, G" sort="Garay Aramburu, G" uniqKey="Garay Aramburu G" first="G" last="Garay-Aramburu">G. Garay-Aramburu</name><affiliation wicri:level="1"><nlm:affiliation>OSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>OSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz</wicri:regionArea><wicri:noRegion>Vitoria-Gasteiz</wicri:noRegion></affiliation></author><author><name sortKey="Mu Oz Negrete, F J" sort="Mu Oz Negrete, F J" uniqKey="Mu Oz Negrete F" first="F J" last="Mu Oz-Negrete">F J Mu Oz-Negrete</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Mendicute Del Barrio, J" sort="Mendicute Del Barrio, J" uniqKey="Mendicute Del Barrio J" first="J" last="Mendicute Del Barrio">J. Mendicute Del Barrio</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián</wicri:regionArea><wicri:noRegion>San Sebastián</wicri:noRegion></affiliation></author><author><name sortKey="Pablo Julvez, L" sort="Pablo Julvez, L" uniqKey="Pablo Julvez L" first="L" last="Pablo-Júlvez">L. Pablo-Júlvez</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza</wicri:regionArea><wicri:noRegion>Zaragoza</wicri:noRegion></affiliation></author><author><name sortKey="Garcia Delpech, S" sort="Garcia Delpech, S" uniqKey="Garcia Delpech S" first="S" last="García-Delpech">S. García-Delpech</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="L Pez Alemany, A" sort="L Pez Alemany, A" uniqKey="L Pez Alemany A" first="A" last="L Pez-Alemany">A. L Pez-Alemany</name><affiliation wicri:level="1"><nlm:affiliation>Universidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Universidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Arnalich Montiel, F" sort="Arnalich Montiel, F" uniqKey="Arnalich Montiel F" first="F" last="Arnalich-Montiel">F. Arnalich-Montiel</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Cordero Coma, M" sort="Cordero Coma, M" uniqKey="Cordero Coma M" first="M" last="Cordero-Coma">M. Cordero-Coma</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León</wicri:regionArea><wicri:noRegion>León</wicri:noRegion></affiliation></author><author><name sortKey="Carceles, J A" sort="Carceles, J A" uniqKey="Carceles J" first="J A" last="Cárceles">J A Cárceles</name><affiliation wicri:level="1"><nlm:affiliation>Clínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Clínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia</wicri:regionArea><wicri:noRegion>Murcia</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32409243</idno><idno type="pmid">32409243</idno><idno type="doi">10.1016/j.oftal.2020.04.002</idno><idno type="pmc">PMC7183292</idno><idno type="wicri:Area/Main/Corpus">001693</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001693</idno><idno type="wicri:Area/Main/Curation">001693</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001693</idno><idno type="wicri:Area/Main/Exploration">001693</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.</title><author><name sortKey="Gegundez Fernandez, J A" sort="Gegundez Fernandez, J A" uniqKey="Gegundez Fernandez J" first="J A" last="Gegúndez-Fernández">J A Gegúndez-Fernández</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid, España. Electronic address: doctorgegundez@gmail.com.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Zarranz Ventura, J" sort="Zarranz Ventura, J" uniqKey="Zarranz Ventura J" first="J" last="Zarranz-Ventura">J. Zarranz-Ventura</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona</wicri:regionArea><wicri:noRegion>Sociedad Española de Retina y Vítreo (SERV) Barcelona</wicri:noRegion></affiliation></author><author><name sortKey="Garay Aramburu, G" sort="Garay Aramburu, G" uniqKey="Garay Aramburu G" first="G" last="Garay-Aramburu">G. Garay-Aramburu</name><affiliation wicri:level="1"><nlm:affiliation>OSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>OSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz</wicri:regionArea><wicri:noRegion>Vitoria-Gasteiz</wicri:noRegion></affiliation></author><author><name sortKey="Mu Oz Negrete, F J" sort="Mu Oz Negrete, F J" uniqKey="Mu Oz Negrete F" first="F J" last="Mu Oz-Negrete">F J Mu Oz-Negrete</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Mendicute Del Barrio, J" sort="Mendicute Del Barrio, J" uniqKey="Mendicute Del Barrio J" first="J" last="Mendicute Del Barrio">J. Mendicute Del Barrio</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián</wicri:regionArea><wicri:noRegion>San Sebastián</wicri:noRegion></affiliation></author><author><name sortKey="Pablo Julvez, L" sort="Pablo Julvez, L" uniqKey="Pablo Julvez L" first="L" last="Pablo-Júlvez">L. Pablo-Júlvez</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza</wicri:regionArea><wicri:noRegion>Zaragoza</wicri:noRegion></affiliation></author><author><name sortKey="Garcia Delpech, S" sort="Garcia Delpech, S" uniqKey="Garcia Delpech S" first="S" last="García-Delpech">S. García-Delpech</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="L Pez Alemany, A" sort="L Pez Alemany, A" uniqKey="L Pez Alemany A" first="A" last="L Pez-Alemany">A. L Pez-Alemany</name><affiliation wicri:level="1"><nlm:affiliation>Universidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Universidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia</wicri:regionArea><wicri:noRegion>Valencia</wicri:noRegion></affiliation></author><author><name sortKey="Arnalich Montiel, F" sort="Arnalich Montiel, F" uniqKey="Arnalich Montiel F" first="F" last="Arnalich-Montiel">F. Arnalich-Montiel</name><affiliation wicri:level="3"><nlm:affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid</wicri:regionArea><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation></author><author><name sortKey="Cordero Coma, M" sort="Cordero Coma, M" uniqKey="Cordero Coma M" first="M" last="Cordero-Coma">M. Cordero-Coma</name><affiliation wicri:level="1"><nlm:affiliation>Hospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Hospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León</wicri:regionArea><wicri:noRegion>León</wicri:noRegion></affiliation></author><author><name sortKey="Carceles, J A" sort="Carceles, J A" uniqKey="Carceles J" first="J A" last="Cárceles">J A Cárceles</name><affiliation wicri:level="1"><nlm:affiliation>Clínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia, España.</nlm:affiliation><country xml:lang="fr">Espagne</country><wicri:regionArea>Clínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia</wicri:regionArea><wicri:noRegion>Murcia</wicri:noRegion></affiliation></author></analytic><series><title level="j">Archivos de la Sociedad Espanola de Oftalmologia</title><idno type="eISSN">2173-5794</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antimalarials (therapeutic use)</term><term>Asymptomatic Diseases (MeSH)</term><term>Betacoronavirus (MeSH)</term><term>Blood Safety (MeSH)</term><term>COVID-19 (MeSH)</term><term>Chloroquine (therapeutic use)</term><term>Contact Lenses (MeSH)</term><term>Coronavirus Infections (diagnosis)</term><term>Coronavirus Infections (epidemiology)</term><term>Coronavirus Infections (prevention & control)</term><term>Coronavirus Infections (transmission)</term><term>Disease Progression (MeSH)</term><term>Eye Diseases (diagnosis)</term><term>Eye Diseases (therapy)</term><term>Humans (MeSH)</term><term>Hydroxychloroquine (therapeutic use)</term><term>Infectious Disease Transmission, Patient-to-Professional (prevention & control)</term><term>Ophthalmologic Surgical Procedures (adverse effects)</term><term>Ophthalmologic Surgical Procedures (methods)</term><term>Ophthalmology (MeSH)</term><term>Pandemics (prevention & control)</term><term>Pneumonia, Viral (diagnosis)</term><term>Pneumonia, Viral (epidemiology)</term><term>Pneumonia, Viral (prevention & control)</term><term>Pneumonia, Viral (transmission)</term><term>Postoperative Complications (prevention & control)</term><term>Risk Factors (MeSH)</term><term>SARS-CoV-2 (MeSH)</term><term>Societies, Medical (MeSH)</term><term>Spain (MeSH)</term><term>Symptom Assessment (methods)</term><term>Withholding Treatment (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Abstention thérapeutique (MeSH)</term><term>Antipaludiques (usage thérapeutique)</term><term>Betacoronavirus (MeSH)</term><term>Chloroquine (usage thérapeutique)</term><term>Complications postopératoires (prévention et contrôle)</term><term>Espagne (MeSH)</term><term>Facteurs de risque (MeSH)</term><term>Humains (MeSH)</term><term>Hydroxychloroquine (usage thérapeutique)</term><term>Infections à coronavirus (diagnostic)</term><term>Infections à coronavirus (prévention et contrôle)</term><term>Infections à coronavirus (transmission)</term><term>Infections à coronavirus (épidémiologie)</term><term>Lentilles de contact (MeSH)</term><term>Maladies asymptomatiques (MeSH)</term><term>Maladies de l'oeil (diagnostic)</term><term>Maladies de l'oeil (thérapie)</term><term>Ophtalmologie (MeSH)</term><term>Pandémies (prévention et contrôle)</term><term>Pneumopathie virale (diagnostic)</term><term>Pneumopathie virale (prévention et contrôle)</term><term>Pneumopathie virale (transmission)</term><term>Pneumopathie virale (épidémiologie)</term><term>Procédures de chirurgie ophtalmologique (effets indésirables)</term><term>Procédures de chirurgie ophtalmologique (méthodes)</term><term>Sociétés médicales (MeSH)</term><term>Sécurité transfusionnelle (MeSH)</term><term>Transmission de maladie infectieuse du patient au professionnel de santé (prévention et contrôle)</term><term>Évaluation des symptômes (méthodes)</term><term>Évolution de la maladie (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antimalarials</term><term>Chloroquine</term><term>Hydroxychloroquine</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>Spain</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Ophthalmologic Surgical Procedures</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Coronavirus Infections</term><term>Eye Diseases</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="diagnostic" xml:lang="fr"><term>Infections à coronavirus</term><term>Maladies de l'oeil</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Procédures de chirurgie ophtalmologique</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Ophthalmologic Surgical Procedures</term><term>Symptom Assessment</term></keywords><keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Procédures de chirurgie ophtalmologique</term><term>Évaluation des symptômes</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term><term>Infectious Disease Transmission, Patient-to-Professional</term><term>Pandemics</term><term>Pneumonia, Viral</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Complications postopératoires</term><term>Infections à coronavirus</term><term>Pandémies</term><term>Pneumopathie virale</term><term>Transmission de maladie infectieuse du patient au professionnel de santé</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Eye Diseases</term></keywords><keywords scheme="MESH" qualifier="thérapie" xml:lang="fr"><term>Maladies de l'oeil</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Antipaludiques</term><term>Chloroquine</term><term>Hydroxychloroquine</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Asymptomatic Diseases</term><term>Betacoronavirus</term><term>Blood Safety</term><term>COVID-19</term><term>Contact Lenses</term><term>Disease Progression</term><term>Humans</term><term>Ophthalmology</term><term>Risk Factors</term><term>SARS-CoV-2</term><term>Societies, Medical</term><term>Withholding Treatment</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Abstention thérapeutique</term><term>Betacoronavirus</term><term>Espagne</term><term>Facteurs de risque</term><term>Humains</term><term>Lentilles de contact</term><term>Maladies asymptomatiques</term><term>Ophtalmologie</term><term>Sociétés médicales</term><term>Sécurité transfusionnelle</term><term>Évolution de la maladie</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Espagne</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b></p><p>Minimize exposure to the SARS-CoV-2, reduce the chances of cross-transmission between patients and healthcare personnel, and prevent the development of postoperative complications from the management of patients with eye diseases during the 2019 coronavirus disease pandemic (COVID-19).</p></div><div type="abstract" xml:lang="en"><p><b>METHODS</b></p><p>COVID-19 literature review and consensus establishment between different Spanish ophthalmology societies in order to provide guidelines and recommendations of maximum resources primarily conditioned by the state of alert, confinement and social distancing that occurs in Spain since March 16, 2020.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>The recommendations will promote the adoption of action and protection measures for eye care in outpatient clinics, surgical areas and hospitalization, for unconfirmed (asymptomatic and symptomatic) and confirmed COVID-19 patients. Measures must be adapted to the circumstances and availability of personal protective equipment in each of the centers and Autonomous Communities, which will be updated according to the pandemic phases and the measures adopted by the Spanish Government.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b></p><p>During the COVID-19 pandemic, attention to the potential health risks to the population caused by coronavirus should prevail over the possible progression of the common eye diseases. Ophthalmologists and other eye care professionals must assume a possible progression of these diseases due to the impossibility of adequate patient follow-up.</p></div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32409243</PMID><DateCompleted><Year>2020</Year><Month>06</Month><Day>10</Day></DateCompleted><DateRevised><Year>2021</Year><Month>05</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5794</ISSN><JournalIssue CitedMedium="Internet"><Volume>95</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Archivos de la Sociedad Espanola de Oftalmologia</Title><ISOAbbreviation>Arch Soc Esp Oftalmol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.</ArticleTitle><Pagination><MedlinePgn>300-310</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S0365-6691(20)30135-0</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.oftal.2020.04.002</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Minimize exposure to the SARS-CoV-2, reduce the chances of cross-transmission between patients and healthcare personnel, and prevent the development of postoperative complications from the management of patients with eye diseases during the 2019 coronavirus disease pandemic (COVID-19).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">COVID-19 literature review and consensus establishment between different Spanish ophthalmology societies in order to provide guidelines and recommendations of maximum resources primarily conditioned by the state of alert, confinement and social distancing that occurs in Spain since March 16, 2020.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The recommendations will promote the adoption of action and protection measures for eye care in outpatient clinics, surgical areas and hospitalization, for unconfirmed (asymptomatic and symptomatic) and confirmed COVID-19 patients. Measures must be adapted to the circumstances and availability of personal protective equipment in each of the centers and Autonomous Communities, which will be updated according to the pandemic phases and the measures adopted by the Spanish Government.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">During the COVID-19 pandemic, attention to the potential health risks to the population caused by coronavirus should prevail over the possible progression of the common eye diseases. Ophthalmologists and other eye care professionals must assume a possible progression of these diseases due to the impossibility of adequate patient follow-up.</AbstractText><CopyrightInformation>Copyright © 2020 Sociedad Española de Oftalmología. Publicado por Elsevier España, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gegúndez-Fernández</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Hospital Clínico San Carlos, Sociedad Española de Oftalmología (SEO), Madrid, España. Electronic address: doctorgegundez@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zarranz-Ventura</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Clinic, Sociedad Española de Retina y Vítreo (SERV) Barcelona, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garay-Aramburu</LastName><ForeName>G</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>OSI Araba, Sociedad Española de Retina y Vítreo (SERV), Vitoria-Gasteiz, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muñoz-Negrete</LastName><ForeName>F J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO) y Sociedad Española de Glaucoma (SEG), Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendicute Del Barrio</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Donostia, Sociedad Española de Cirugía Ocular Implanto-Refractiva (SECOIR), San Sebastián, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pablo-Júlvez</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Hospital Universitario Miguel Servet, Sociedad Española de Glaucoma (SEG), Zaragoza, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>García-Delpech</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hospital Universitario La Fe, Sociedad Española de Contactología (SEC) y Sociedad Española de Oftalmología (SEO), Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>López-Alemany</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Universidad de Valencia, Sociedad Española de Contactología (SEC), Xátiva, Valencia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arnalich-Montiel</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Ramón y Cajal, Sociedad Española de Oftalmología (SEO), Madrid, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cordero-Coma</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Léon, Sociedad Española de Inflamación Ocular (SEIOC), León, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cárceles</LastName><ForeName>J A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Clínica Coatvisión, Sociedad Española de Oftalmología (SEO), Murcia, España.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Sociedades oftalmológicas españolas</CollectiveName></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Recomendaciones para la atención oftalmológica durante el estado de alarma por la pandemia de enfermedad por coronavirus COVID-19.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Arch Soc Esp Oftalmol (Engl Ed)</MedlineTA><NlmUniqueID>101715860</NlmUniqueID><ISSNLinking>2173-5794</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000962">Antimalarials</NameOfSubstance></Chemical><Chemical><RegistryNumber>4QWG6N8QKH</RegistryNumber><NameOfSubstance UI="D006886">Hydroxychloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000962" MajorTopicYN="N">Antimalarials</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058070" MajorTopicYN="N">Asymptomatic Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="Y">Betacoronavirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058731" MajorTopicYN="N">Blood Safety</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003261" MajorTopicYN="N">Contact Lenses</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005128" MajorTopicYN="N">Eye Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006886" MajorTopicYN="N">Hydroxychloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017758" MajorTopicYN="N">Infectious Disease Transmission, Patient-to-Professional</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013508" MajorTopicYN="N">Ophthalmologic Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009885" MajorTopicYN="N">Ophthalmology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="Y">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName><QualifierName UI="Q000635" MajorTopicYN="Y">transmission</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012955" MajorTopicYN="N">Societies, Medical</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063189" MajorTopicYN="N">Symptom Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D028761" MajorTopicYN="N">Withholding Treatment</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atención oftalmológica</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Eye care</Keyword><Keyword MajorTopicYN="N">Oftalmología</Keyword><Keyword MajorTopicYN="N">Ophthalmology</Keyword><Keyword MajorTopicYN="N">Pandemia</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">Recomendaciones</Keyword><Keyword MajorTopicYN="N">Recommendations</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>04</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>04</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>6</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>5</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32409243</ArticleId><ArticleId IdType="pii">S0365-6691(20)30135-0</ArticleId><ArticleId IdType="doi">10.1016/j.oftal.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7183292</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Eye (Lond). 2020 Feb 6;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32029919</ArticleId></ArticleIdList></Reference><Reference><Citation>EClinicalMedicine. 2020 Apr 5;:100331</Citation><ArticleIdList><ArticleId IdType="pubmed">32292899</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2020 Feb 26;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32100876</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar 20;:105949</Citation><ArticleIdList><ArticleId IdType="pubmed">32205204</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Ophthalmol. 2020 May;213:A1-A2</Citation><ArticleIdList><ArticleId IdType="pubmed">32169251</ArticleId></ArticleIdList></Reference><Reference><Citation>Ann Intern Med. 2020 May 5;172(9):577-582</Citation><ArticleIdList><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference><Reference><Citation>Ophthalmology. 2016 Jun;123(6):1386-94</Citation><ArticleIdList><ArticleId IdType="pubmed">26992838</ArticleId></ArticleIdList></Reference><Reference><Citation>Graefes Arch Clin Exp Ophthalmol. 2020 May;258(5):1049-1055</Citation><ArticleIdList><ArticleId IdType="pubmed">32124000</ArticleId></ArticleIdList></Reference><Reference><Citation>Br J Ophthalmol. 2020 Mar;104(3):297-298</Citation><ArticleIdList><ArticleId IdType="pubmed">32086236</ArticleId></ArticleIdList></Reference><Reference><Citation>Cir Esp. 2020 May;98(5):251-259</Citation><ArticleIdList><ArticleId IdType="pubmed">32252979</ArticleId></ArticleIdList></Reference><Reference><Citation>Eye (Lond). 2018 Jul;32(7):1168-1173</Citation><ArticleIdList><ArticleId IdType="pubmed">29887605</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation><ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Glob Health. 2020 Apr;8(4):e488-e496</Citation><ArticleIdList><ArticleId IdType="pubmed">32119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Ophthalmol. 2020 May;213:A3-A4</Citation><ArticleIdList><ArticleId IdType="pubmed">32247518</ArticleId></ArticleIdList></Reference><Reference><Citation>J Crit Care. 2020 Jun;57:279-283</Citation><ArticleIdList><ArticleId IdType="pubmed">32173110</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 21;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32083643</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Espagne</li></country><region><li>Communauté de Madrid</li></region><settlement><li>Madrid</li></settlement></list><tree><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Gegundez Fernandez, J A" sort="Gegundez Fernandez, J A" uniqKey="Gegundez Fernandez J" first="J A" last="Gegúndez-Fernández">J A Gegúndez-Fernández</name></region><name sortKey="Arnalich Montiel, F" sort="Arnalich Montiel, F" uniqKey="Arnalich Montiel F" first="F" last="Arnalich-Montiel">F. Arnalich-Montiel</name><name sortKey="Carceles, J A" sort="Carceles, J A" uniqKey="Carceles J" first="J A" last="Cárceles">J A Cárceles</name><name sortKey="Cordero Coma, M" sort="Cordero Coma, M" uniqKey="Cordero Coma M" first="M" last="Cordero-Coma">M. Cordero-Coma</name><name sortKey="Garay Aramburu, G" sort="Garay Aramburu, G" uniqKey="Garay Aramburu G" first="G" last="Garay-Aramburu">G. Garay-Aramburu</name><name sortKey="Garcia Delpech, S" sort="Garcia Delpech, S" uniqKey="Garcia Delpech S" first="S" last="García-Delpech">S. García-Delpech</name><name sortKey="L Pez Alemany, A" sort="L Pez Alemany, A" uniqKey="L Pez Alemany A" first="A" last="L Pez-Alemany">A. L Pez-Alemany</name><name sortKey="Mendicute Del Barrio, J" sort="Mendicute Del Barrio, J" uniqKey="Mendicute Del Barrio J" first="J" last="Mendicute Del Barrio">J. Mendicute Del Barrio</name><name sortKey="Mu Oz Negrete, F J" sort="Mu Oz Negrete, F J" uniqKey="Mu Oz Negrete F" first="F J" last="Mu Oz-Negrete">F J Mu Oz-Negrete</name><name sortKey="Pablo Julvez, L" sort="Pablo Julvez, L" uniqKey="Pablo Julvez L" first="L" last="Pablo-Júlvez">L. Pablo-Júlvez</name><name sortKey="Zarranz Ventura, J" sort="Zarranz Ventura, J" uniqKey="Zarranz Ventura J" first="J" last="Zarranz-Ventura">J. Zarranz-Ventura</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D57 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D57 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32409243
|texte= Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32409243" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidChloroV1
| This area was generated with Dilib version V0.6.38. |  |